Comments for OneMedPlace - Sentinel

Comment on BREAKING NEWS: Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer by srebrenik shalom

srebrenik shalom — Mon, 30 Jan 2012 10:12:02 +0000

we invested a lot of money in ADXS from the very begining and we wait eagerly for the results
we could not understand their significance because there is not a clear comparison to the reference group
please!

Comment on BREAKING NEWS: Advaxis Reports Preliminary Safety and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer by Alan S. Frankel

Alan S. Frankel — Fri, 27 Jan 2012 15:39:35 +0000

This conference call was excellent and I hope to follow Advaxis on your site

Comment on Novartis’ NVA237 improves lung function in pulmonary disease patients by Copd untreated

Copd untreated — Wed, 25 Jan 2012 14:37:41 +0000

What's COPD? COPD = continual Obstructive lung. Do you know the principal elements to the introduction and also exacerbation from the condition lively along with passive using tobacco is …copd

Comment on This Week In Diagnostics by nicolette richards

nicolette richards — Wed, 25 Jan 2012 09:56:39 +0000

I am 19 years old and I have trisomy 20 mosaicism and I was curious if there are any new developments on that or any research being conducted?

Comment on Neovasc’s Refractory Angina Treatment Receives CE Mark by Tips to help manage angina | Heartattack Signs Of

Tips to help manage angina | Heartattack Signs Of — Fri, 09 Dec 2011 08:57:46 +0000

[...] product can be marketed for implantation in patients in the European Union, … Read more on OneMedPlace (blog) This entry was posted in Heart Attack Signs in Women and tagged angina, Help, manage, Tips by [...]

Comment on Neovasc’s Refractory Angina Treatment Receives CE Mark by Latest Angina News | Heartattack for Women

Latest Angina News | Heartattack for Women — Fri, 09 Dec 2011 06:25:33 +0000

[...] Neovasc's Refractory Angina Treatment Receives CE Mark The company just announced that it has received the CE mark approval for its Reducer product, which was developed to treat refractory angina. The CE reveals that the product can be marketed for implantation in patients in the European Union, … Read more on OneMedPlace (blog) [...]

Comment on Advaxis CEO Tom Moore Discovers A New Way To Fight Cancer by eric

eric — Fri, 02 Dec 2011 02:24:58 +0000

brett,
thanks for this interview i just became a shareholder.. im excited im looking forward to hearing follow ups to the progress of advaxis..
happy holidays..
Eric

Comment on Keating Capital Raises $86 million to fund Pre-IPO companies. by Jonathan Stuart

Jonathan Stuart — Sun, 13 Nov 2011 13:44:44 +0000

Pre-IPO funds are also run by MidasLP.com, GSV and several other funds.

Comment on [Video] Interview with Tom Steinke, CEO and Founder of Minnow Medical by Jason Temper

Jason Temper — Fri, 11 Nov 2011 00:55:37 +0000

This is a serious condition. Please raise awareness. Becareful with pain or unusual aches in your legs. Consult your doctor if you feel anything out of the ordinary.

Comment on [Video] Interview with Tom Steinke, CEO and Founder of Minnow Medical by Adam Biggens

Adam Biggens — Fri, 11 Nov 2011 00:31:10 +0000

Please see your doctor if you suspect yourself of symptoms for PAD.